DANIELLE DURNAN: Open Payments
NPI 1306181656 · DEWEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 25 payments from 12 companies in 2025. Trend: 2023 $511 · 2024 $590 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $274 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: AIRSUPRA, BEVESPI AEROSPHERE, BREZTRI, TRELEGY ELLIPTA, Kerendia, The Cologuard Plus Collection Kit, Veozah, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
